Article

HaaretzHaaretz on 2017-11-12 05:00

In Blow to Tel Aviv Stock Exchange, Pharma Jewel Mylan to Delist Shares

Israeli institutional investors increased their holdings in Mylan after realizing its advantages over Teva. Its shares account for 7% of the total ...

Related news